rTMS Treatment for Depression

TMS and rTMS: An introduction to the Basic Principles of TMS and rTMS.- The History of TMS and rTMS Treatment of Depression.- The Mechanism of action of rTMS.- Acute rTMS treatment for MDD.- Acute rTMS treatment for MDD, clinical indications / patient selection.- Practical Issues in Treatment Provision.- Switching, Continuing or Ending treatment.- The Use of Deep Transcranial Magnetic Stimulation in Depression.- Theta Burst Stimulation (TBS) in rTMS Therapy.- Accelerated and Intensive rTMS Treatment Protocols.- Localization and Targeting of rTMS Treatment of Depression.- Treatment Intensity, the Resting Motor Threshold and rTMS Treatment Dosing.- Maintenance and Continuation Treatment.- rTMS Associated Adverse events, Safety and Monitoring.- Side Effects of rTMS Treatment.- The Use of rTMS in Other Psychiatric Disorders.- Equipment and rTMS Program Set up.

Paul Fitzgerald is Professor of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health based at Epworth Camberwell in Victoria, Australia. He is a qualified psychiatrist, has a Masters of Psychological Medicine and research PhD. His main clinical and academic interest is in the development, evaluation and clinical translation of new therapies for mental health conditions. He has conducted over twenty randomised clinical trials of forms of brain stimulation in depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer's disease along with over 50 experimental studies. He has established multiple clinical TMS services, is a founder and board member of TMS Clinics Australia, and established Australia's first TMS clinical training program. He has had continual federal grant support for almost 20 years and is currently an NHMRC Leadership grant holder.

Zafiris 'Jeff' Daskalakis is the newly appointed Chair of the Department of Psychiatry at UCSD. He was formerly the Temerty Chair and Chief of the General Adult Psychiatry at CAMH. His research focusses on neurophysiological and treatment studies using transcranial magnetic brain stimulation (rTMS) and magnetic seizure therapy (MST). He has established Canada's first TMS clinical training program and he holds or has held numerous federal operating grants and awards, including grants from the NIH and CIHR. He has received over $50 million in research funding as PI, has over 440 peer-reviewed publications, and is an editorial board member for Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and an Associate Editor for Clinical Neurophysiology. He is also a member of the Brain and Behavior Research Foundation (formerly NARSAD) Scientific Council.